Production (Stage)
Amarin Corporation plc
AMRN
$11.11
$0.121.09%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/23/2025
-
Zacks Investment Research
5/23/2025
-
Zacks Investment Research
5/21/2025
-
Zacks Investment Research
5/21/2025
-
Tickeron - Technical Analysis
5/20/2025
-
Zacks Investment Research
5/14/2025
-
Tickeron - Stocks
5/10/2025
-
Tickeron - Technical Analysis
5/8/2025
-
Zacks Investment Research
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/7/2025
-
SeekingAlpha
5/7/2025
-
Seeking Alpha: Transcripts
5/7/2025
-
SeekingAlpha
5/7/2025
-
GuruFocus
5/7/2025
-
GuruFocus
5/7/2025
-
GuruFocus
5/7/2025
-
Globe Newswire
5/6/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/29/2025
-
GuruFocus
4/29/2025
-
TipRanks Financial Blog
4/29/2025
-
Globe Newswire
4/29/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 7, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of July (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
353 0 166 99020
Address
One Central Plaza
5th Floor - 36 Dame Street
Dublin 2, D02 K7K5
5th Floor - 36 Dame Street
Dublin 2, D02 K7K5
Country
Year Founded
Business Description
Sector
--
Industry
--
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and...
more